Newsroom

Danguole Altman, the CEO of CX Precision Medicine, recently sat down for an interview on the Innovate Fort Worth podcast, produced by HSC Next at The University of North Texas Health Science Center at Fort Worth. During the podcast, Altman discussed her company’s work in the field of Alzheimer’s disease diagnostics and the novel technology her team is using to develop their products.

CX Precision Medicine is a leading health care company that specializes in Alzheimer’s disease diagnostics using blood-based biomarkers. Its Alzheimer’s disease diagnostic test is based on a novel technology developed by world-renowned researcher Dr. Sid O’Bryant, and it has the potential to revolutionize the way that Alzheimer’s disease is diagnosed and treated. Additional applications for their technology include personalized medicine treatments for specific patient populations to treat Alzheimer’s disease, Parkinson’s Disease and similar neurodegenerative conditions.

During the podcast, Altman discussed the importance of early detection in the fight against Alzheimer’s disease and the role that CX Precision Medicine is playing in developing new, more effective diagnostic tools. She explained that their diagnostic test uses a combination of biomarkers and genetic information to provide early and accurate detection of the disease, which is critical for improving patient outcomes.

“We believe that early detection is key to fighting Alzheimer’s Disease,” Altman said during the podcast. “With our diagnostic test, we’re able to provide accurate and reliable results that can help doctors detect Alzheimer’s disease earlier and start treatment sooner.”

Altman also discussed the challenges that her company has faced in developing its test and the importance of partnerships with leading researchers like O’Bryant. She explained that CX Precision Medicine is committed to working with the best and brightest minds in the field of Alzheimer’s disease research to develop new, more effective treatments and diagnostic tools.

“We’re honored to be working with Dr. Sid O’Bryant and his team at HSC,” Altman said. “Their expertise and insights have been invaluable in helping us develop our diagnostic test and other products, and we’re excited to continue collaborating with them in the future.”

The Innovate Fort Worth podcast is produced by HSC Next, a team at The University of North Texas Health Science Center at Fort Worth dedicated to promoting innovation and entrepreneurship in health care. The podcast features interviews with leaders in the entrepreneurial ecosystem, including scientists, researchers, entrepreneurs and investors. The podcast has quickly become a go-to resource for those looking to stay up to date on the latest trends and developments in the field.

“We’re thrilled to have Danguole Altman on the Innovate Fort Worth podcast,” said Cameron Cushman, the host of the podcast. “Her insights into the field of Alzheimer’s disease diagnostics are invaluable, and her company’s work is making a real difference in the lives of patients around the world. We’re excited to see what the future holds for CX Precision Medicine and the broader field of personalized medicine.”

• Share
• Tweet